We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada. Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.
Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the 43rd Annual J.P...
EFFICACY: In the pivotal studies, ADORING 1 and ADORING 2, up to 46% of patients on VTAMA cream achieved vIGA-AD™ treatment success at Week 8 versus 18% of patients on vehicle. POWERFUL SKIN...
Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced that the U.S. Food and Drug Administration (FDA) extended by...
(ビジネスワイヤ) -- シャンハイ・ヘンリウス・バイオテック(2696.HK)とオルガノン(NYSE:OGN)は、米国食品医薬品局(FDA)がPROLIA/XGEVA(デノスマブ)の治験中のバイオシミラーであるHLX14の生物学的...
(美國商業資訊)-- Shanghai Henlius Biotech, Inc. (2696.HK)和Organon (NYSE: OGN)宣布,美國食品藥物管理局(FDA)已接受PROLIA/XGEVA(地諾單抗)的試驗性生物學名藥HLX14的生物製品授權申請(BLA)。 本新聞稿包...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.49 | -3.23432343234 | 15.15 | 15.41 | 14.385 | 4006727 | 14.76341137 | CS |
4 | -0.365 | -2.42928452579 | 15.025 | 16.29 | 14.385 | 3072506 | 15.26503163 | CS |
12 | -4.73 | -24.3940175348 | 19.39 | 19.41 | 14.385 | 2733601 | 16.37516259 | CS |
26 | -5.56 | -27.4975272008 | 20.22 | 23.1 | 14.385 | 2183846 | 18.14204726 | CS |
52 | 1.12 | 8.2717872969 | 13.54 | 23.1 | 13.14 | 2343297 | 17.87530933 | CS |
156 | -15.34 | -51.1333333333 | 30 | 39.475 | 10.835 | 2380754 | 21.84105178 | CS |
260 | -19.54 | -57.134502924 | 34.2 | 39.475 | 10.835 | 2474605 | 23.73025449 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions